|
2025
|
Invention
|
Interleukin-2 polypeptides, fusion polypeptides, and methods of use thereof.
IL-2 variant polype... |
|
|
Invention
|
T-cell modulatory multimeric polypeptides and methods of use thereof.
The present disclosure pro... |
|
2024
|
Invention
|
Tgf-beta polypeptides.
The present disclosure provides Transforming Growth Factor Beta (TGF-β) p... |
|
|
Invention
|
Methods for modulating an immune response.
The present disclosure provides methods of modulating... |
|
|
Invention
|
Mhc class ii protein complexes. The present disclosure provides Multimeric Antigen-Presenting Pol... |
|
|
Invention
|
Methods for treating hpv16-associated cancers. This disclosure provides a method of treating an H... |
|
|
Invention
|
Modified cytotoxic t cells and methods of use thereof.
The present disclosure provides modified ... |
|
|
Invention
|
Immune cell binding polypeptides.
The present disclosure provides immune cell binding polypeptid... |
|
|
Invention
|
T-cell modulatory polypeptides and methods of use thereof.
The present disclosure provides T-cel... |
|
|
Invention
|
T-cell engaging polypeptides and methods of use thereof.
The present disclosure provides a singl... |
|
|
Invention
|
Multimeric t-cell modulatory polypeptides and methods of use thereof.
The present disclosure pro... |
|
|
Invention
|
T-cell modulatory polypeptides and methods of use thereof. The present disclosure provides a sing... |
|
|
Invention
|
T-cell modulatory polypeptides and methods of use thereof. The present disclosure provides a T-ce... |
|
|
Invention
|
T cell modulatory polypeptides with conjugation sites and methods of use thereof.
The present di... |
|
|
Invention
|
T-cell modulatory polypeptides and methods of use thereof. The present disclosure provides a pept... |
|
|
Invention
|
Mhc class ii t-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (t1d... |
|
|
Invention
|
T-cell modulatory multimeric polypeptide with conjugation sites and methods of use thereof.
The ... |
|
|
G/S
|
Biopharmaceutical preparations for treating cancer, autoimmune diseases and infectious diseases; ... |
|
2023
|
Invention
|
Multimeric t-cell modulatory polypeptides and methods of use thereof. The present disclosure prov... |
|
|
Invention
|
T-cell modulatory multimeric polypeptides and methods of use thereof. The present disclosure prov... |
|
|
Invention
|
Mhc class ii t-cell modulatory polypeptides and methods of use thereof.
The present disclosure p... |
|
|
Invention
|
Mhc class ii t-cell modulatory polypeptides for treating type 1 diabetes mellitus (t1d) and metho... |
|
|
Invention
|
Interleukin-2 polypeptides, fusion polypeptides, and methods of use thereof. IL-2 variant polypep... |
|
|
Invention
|
Mhc class ii protein constructs. Disclosed are MHC Class II constructs (CIICs) comprising DQ and ... |
|
|
Invention
|
Proteins for modulating cell therapy products and methods of use thereof.
This disclosure provid... |
|
|
Invention
|
Antigen-presenting polypeptides and methods of use thereof.
The present disclosure provides anti... |
|
2022
|
Invention
|
Antigen presenting polypeptide complexes and methods of use thereof.
The present disclosure prov... |
|
|
Invention
|
Antigen-presenting polypeptides with chemical conjugation sites and methods of use thereof.
The ... |
|
|
Invention
|
Antigen presenting polypeptide complexes bearing tgf-beta and methods of use thereof.
The presen... |
|
2021
|
Invention
|
T-cell modulatory polypeptides with conjugation sites and methods of use thereof.
The present di... |
|
|
G/S
|
Reagents for scientific or medical research use, not in relation to ear lotions and/or other topi... |
|
2020
|
G/S
|
Biopharmaceutical preparations for treating cancer and autoimmune diseases; immunotherapeutic pre... |
|
2017
|
G/S
|
Reagents for scientific or medical research use. Biologic preparations; biologic preparations con... |
|
|
G/S
|
Diagnostic reagents for medical-scientific research use.
Biologic preparations containing immunot... |
|
2016
|
G/S
|
Medical research |
